TheraputicsMD sells products rights for $153 million

    0
    126

    Four members of the company’s board of directors also resigned, according to the SEC filing.

    Advertisment
    Previous articleRestrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up
    Next articleA Valuable COVID Drug Doesn’t Work against New Variants

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here